By Amanda Frost, PhD Vice President, Research, PCMA There is no shortage of opinions these days about GLP-1 prescription drugs: touting benefits for patients
Were using the least amount needed because theyre also getting set up with dietary modifications, hormonal and thyroid management, and help with decreasing inflammation. These combined interventions support metabolic health while someone is taking the drug and after they stop using it, she adds
Semaglutide mainly affects how your body regulates hunger and blood sugar, while Prozac works on your brains serotonin levels to improve mood
announced it would discontinue developing danuglipron, an oral GLP-1 receptor agonist for chronic weight management
Impact on NAION A paper published in 2024 in JAMA Ophthalmology created shock waves in the ophthalmic community by showing that subcutaneous semaglutide was associated with a significantly higher risk of developing nonarteritic anterior ischemic optic neuropathy (NAION)